Mechanisms of acupuncture and moxibustion in regulation of epithelial cell apoptosis in rat ulcerative colitis

World Journal of Gastroenterology

Volumn 10, Issue 5, 2004, Pages 682-688

  Wu, Huan Gan ^a,b   Gong, Xiao ^a,b   Yao, Li Qing ^c   Zhang, Wei ^a,b   Shi, Yin ^a,b   Liu, Hui Rong ^a,b   Gong, Ye Jing ^a,b   Zhou, Li Bin ^d   Zhu, Yi ^a,b  

^a Shanghai Institute of Acupuncture Moxibustion and Meridian   (China)

^b Center of Acupuncture and Meridian   (China)

^c ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^d SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITUM EXTRACT; CINNAMOMI CORTEX EXTRACT; FAS ANTIGEN; FAS LIGAND; HERBACEOUS AGENT; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ALTERNATIVE MEDICINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; COLON; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ELECTROACUPUNCTURE; EPITHELIUM CELL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL PROCEDURES; IMMUNOSTIMULATION; INTESTINE CELL; MALE; NICK END LABELING; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REGULATORY MECHANISM; ULCERATIVE COLITIS;

EID: 1542580386     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i5.682     Document Type: Article

References (56)

1. Xia B, Shivananda S, Zhang GS, Yi JY, Crusius JBA, Peña AS. Inflammatory bowel disease in Hubei Province of China. China Natl J New Gastroenterol 1997; 3: 119-120
2. Xia B, Guo HJ, Crusius JBA, Deng CS, Meuwissen SGM, Peña AS. In vitro production of TNF-α, IL-6 and sIL-2R in Chinese patients with ulcerative colitis. World J Gastroenterol 1998; 4: 252-255
3. Hu QY, Hu XY, Jiang Y. Clinical investigation of ulcerative colitis patients treated by integrated traditional Chinese and Western medicine. World J Gastroenterol 1998; 4(Suppl 2): 93-94
4. Xu SY, Bian RL, Chen X. Experimental methodology of pharmacology. Beijing: People's Health Publishing House 1982: 892
5. Seidelin JB, Nielsen OH. Apoptosis in chronic inflammatory bowel disease. The importance for pathogenesis and treatment. Ugeskr Laeger 2003; 165: 790-792
6. Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, Kawauchi Y, Kawachi H, Shimizu F, Matsushima K, Asakura H, Narumi S. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol 2002; 32: 3197-3205
7. Vetuschi A, Latella G, Sferra R, Caprilli R, Gaudio E. Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci 2002; 47: 1447-1457
8. Sipos F, Molnar B, Zagoni T, Tulassay Z. Changes in cell kinetics and clinical course in inflammatory bowel diseases. Orv Hetil 2002; 143: 1175-1181
9. Buttke TM, Sandstrom PA. Oxidative stress as a mediator of apoptosis. Immunol Today 1994; 15: 7-10
10. Arai N, Mitomi H, Ohtani Y, Igarashi M, Kakita A, Okayasu I. Enhanced epithelial cell turnover associated with p53 accumulation and high p21WAF/CIP1 expression in ulcerative colitis. Mod Pathol 1999; 12: 604-611
11. Bu P, Keshavarzian A, Stone DD, Liu J, Le PT, Fisher S, Qiao L. Apoptosis: One of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system. J Immunol 2001; 166: 6399-6403
12. Sasaki S, Yoneyama H, Suzuki K, Suriki H, Aiba T, Watanabe S, Kawauchi Y, Kawachi H, Shimizu F, Matsushima K, Asakura H, Narumi S. Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival. Eur J Immunol 2002; 32: 3197-3205
13. Dieckgraefe BK, Crimmins DL, Landt V, Houchen C, Anant S, Porche-Sorbet R, Ladenson JH. Expression of the regenerating gene family in inflammatory bowel disease mucosa: Reg Ialpha upregulation, processing, and anti apoptotic activity. J Investig Med 2002; 50: 421-434
14. Ruemmele FM, Seidman EG. Cytokine - intestinal epithelial cell interactions: Implications for immune mediated bowel disorders. Zhonghua Minguo Xiaoer Keyi Xuehui Zazhi 1998; 39: 1-8
15. Huang XM. Bcl-2 with its protein and regulation of apoptosis. Foreign Med Sci Sec Mol Biol 1997; 19: 16-19
16. Wu K, Zhao Y. Investigation progres of apoptosis. Foreign Med Sci Sec Mol Biol 2001; 24: 134-136
17. Mercer WE, Shields MT, Lin D, Appella E, Ullrich SJ. Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating cell nuclear antigen expression. Proc Natl Acad Sci U S A 1991; 88: 1958-1962
18. Ohman L, Franzen L, Rudolph U, Birnbaumer L, Hornquist EH. Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis. Gut 2002; 51: 392-397
19. Yan J, Ouyang Q, Liu WP, Li GD, Li FY. Apoptosis and proliferation of epithelial cells in ulcerative colitis. Zhonghua Xiaohua Neijing Zazhi 2001; 18: 161-163
20. Jiang XL, Quan QZ, Sun ZQ, Wang YJ, Qi F, Wang D, Zhang XL. The expression of apoptosis adjust protein of ulcerative colitis patien's lymphocyte. Shijie Huaren Xiaohua Zazhi 1999; 7: 903-904
21. Mayer B, Oberbauer R. Mitochondrial regulation of apoptosis. News Physiol Sci 2003; 18: 89-94
22. Buduneli E, Genel F, Atilla G, Kutukculer N. Evaluation of p53, bcl-2, and interleukin-15 levels in gingival crevicular fluid of cyclosporin A-treated patients. J Periodontol 2003; 74: 506-511
23. Sohn SK, Jung JT, Kim DH, Kim JG, Kwak EK, Park T, Shin DG, Sohn KR, Lee KB. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma. Am J Hematol 2003; 73: 101-107
24. Chiu. CT, Yeh TS, Hsu JC, Chen MF. Expression of Bcl-2 family modulated through p53-dependent pathway in human hepatocellular carcinoma. Dig Dis Sci 2003; 48: 670-676
25. Korkolopoulou P, Lazaris ACH, Konstantinidou AE, Kavantzas N, Patsouris E, Christodoulou P, Thomas-Tsagli E, Davaris P. Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol 2002; 41: 274-283
26. Scorrano L, Korsmeyer SJ. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun 2003; 304: 437-444
27. 0ltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619
28. Korkolopoulou P, Oates J, Kittas C, Crocker J. p53, c-myc, p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas. J Clin Pathol 1994; 47: 9-14
29. Iimura M, Nakamura T, Shinozaki S, Iizuka B, Inoue Y, Suzuki S, Hayashi N. Bax is downregulated in inflammed colonic mucosa of ulcerative colitis. Gut 2000; 47: 228-235
30. Mueller E, Vieth M, Stolte M, Mueller J. The differentiation of true adenomas from colitis-associated dysplasia in ulcerative colitis: a comparative immunohistochemical study. Hum Pathol 1999; 30: 898-905
31. Ina K, Itoh J, Fukushima K, Kusugami K, Yamaguchi T, Kyokane K, Imada A, Binion DG, Musso A, West GA, Dobrea GM, McCormick TS, Lapetina EG, Levine AD, Ottaway CA, Fiocchi C. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance. J Immunol 1999; 163: 1081-1090
32. Kraus MD, Shahsafaei A, Antin J, Odze RD. Relationship of Bcl-2 expression with apoptosis and proliferation in colonic graft versus host disease. Hum Pathol 1998; 29: 869-875
33. Ilyas M, Tomlinson IP, Hanby AM, Yao T, Bodmer WF, Talbot IC. Bcl-2 expression in colorectal. tumors: Evidence of different pathways in sporadic and ulcerative-colitis-associated carcinomas. Am J Pathol 1996; 149: 1719-1726
34. Itoh J, de La Motte C, Strong SA, Levine AD, Fiocchi C. Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease. Gut 2001; 49: 35-41
35. Cui YF, Xia GW, Fu XB, Yang H, Peng RY, Zhang Y, Gu QY, Gao YB, Cui XM, Hu WH. Relationship between expression of Bax and Bcl-2 proteins and apoptosis in radiation compound wound healing of rats. Chin J Traumatol 2003; 6: 135-138
36. Nagata S, Golstein P. The Fas death factor. Science 1995; 267: 1449-1456
37. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Moller P. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis. Gastroenterology 1997; 113: 160-167
38. Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol 1996; 180: 152-159
39. Iwamoto M, Makiyama K, Koji T, Kohno S, Nakane PK. Expression of Fas and Fas-ligand in epithelium of ulcerative colitis. Nippon Rinsho 1996; 54: 1970-1974
40. Mountz JD, Zhou T, Su X, Wu J, Cheng J. The role of programmed cell death as an emerging new concept for the pathogenesis of automimune diseases. Clin Immunol Immunopathol 1996; 80(3 Pt 2): S2-14
41. Nagata S. Fas and Fas ligand: A death factor and its receptor.Adv Immunol 1994; 57: 129-144
42. Yukawa M, Iizuka M, Horie Y, Yoneyama K, Shirasaka T, Itou H, Komatsu M, Fukushima T, Watanabe S. Systemic and local evidence of increased Fas-mediated apoptosis in ulcerative colitis. Int J Colorectal Dis 2002; 17: 70-76
43. Coffey JC, Bennett MW, Wang JH, O'Connell J, Neary P, Shanahan F, Redmond HP, Kirwan WO. Upregulation of Fas-Fas-L (CD95/CD95L)-mediated epithelial apoptosis - a putative role in pouchitis? J Surg Res 2001; 98: 27-32
44. Iwamoto M, Makiyama K, Koji T, Kohno S, Nakane PK. Expression of Fas and Fas-ligand in epithelium of ulcerative colitis. Nippon Rinsho 1996; 54: 1970-1974
45. Moller P, von Reyher U, Leithauser F, Strater J. CD95 (APO-1/Fas) and CD95-ligand (CD95L). Implications of these apoptosis mediating receptor/ligand systems in the pathogenesis of autoimmune diseases. Verh Dtsch Ges Pathol 1996; 80: 12-22
46. Wu HG, Zhou LB, Shi DR, Liu SM, Liu HR, Zhang BM, Chen HP, Zhang LS. Morphological study on colonic pathology in ulcerative colitis treated by moxibustion. World J Gastroenterol 2000; 9: 861-865
47. Tsukada Y, Nakamura T, Iimura M, Iizuka BE, Hayashi N. Cytokine profile in colonic mucosa of ulcerative colitis correlates with disease activity and response to granulocytapheresis. Am J Gastroenterol 2002; 97: 2820-2828
48. Banks C, Bateman A, Payne R, Johnson P, Sheron N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J Pathol 2003; 199: 28-35
49. Brown KA, Back SJ, Ruchelli ED, Markowitz J, Mascarenhas M, Verma R, Piccoli DA, Baldassano RN. Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. Am J Gastroenterol 2002; 97: 2603-2608
50. Ueyamam H, Kiyohara T, Sawada N, Isozaki K, Kitamura S, Kondo S, Miyagawa J, Kanayama S, Shinomura Y, Ishikawa H, Ohtani T, Nezu R, Nagata S, Matsuzawa Y. Hish Fas ligand expression on lymphocytes in lesions of ulcerative colitis. Gut 1998; 43: 48-55
51. Strater J, Wellisch I, Riedl S, Walczak H, Koretz K, Tandara A, Krammer PH, Moller P. CD95(APO-1/Fas)-mediated apoptosis in colon epithelial cells:a possible role in ulcerative colitis. Gastroenterology 1997; 113: 160-167
52. Suzuki A, Sugimura K, Ohtsuka K, Hasegawa K, Suzuki K, Ishizuka K, Mochizuki T, Honma T, Narisawa R, Asakura H. Fas/Fas ligand expression and characteristics of primed CD45RO+ T cells in the inflamed mucosa of ulcerative colitis. Scand J Gastroenterol 2000; 35: 1278-1283
53. Wu HG, Chen HP, Shi Z, Hua XG, Zhao C. Clinical study of the treatment of chronic ulcerative colitis with moxibustion. Int J Clin Acupunct 1999; 1: 26-28
54. Wu HG, Shi Z, Zhou LB, Pan YY, Tan WL. Acupuncture and moxibustion's effect on cytokine of ulcerative colitis rat. Int J Clin Acupunct 2000; 3: 43-48
55. Wu HG, Zhou LB, Huang C, Pan YY, Chen HP, Shi Z, Hua XG. Gene expression of cytokines in acupuncture and moxibustion treatment for ulcerative colitis in rats. Huaren Xiaohua Zazhi 1998; 6: 853-855
56. Wu HG, Chen HP, Zhou LB, Pan YY, Huang C, Shi Z. molecu mechanism of acupuncture and moxibustion's therapy effect on ulcerative colitis rat. Shanghai Zhenjiu Zazhi 1998; 17: 30